<code id='B53417ED59'></code><style id='B53417ED59'></style>
      • <acronym id='B53417ED59'></acronym>
      <center id='B53417ED59'><center id='B53417ED59'><tfoot id='B53417ED59'></tfoot></center><abbr id='B53417ED59'><dir id='B53417ED59'><tfoot id='B53417ED59'></tfoot><noframes id='B53417ED59'>
      • <optgroup id='B53417ED59'><strike id='B53417ED59'><sup id='B53417ED59'></sup></strike><code id='B53417ED59'></code></optgroup>
        5. <b id='B53417ED59'><label id='B53417ED59'><select id='B53417ED59'><dt id='B53417ED59'><span id='B53417ED59'></span></dt></select></label></b><u id='B53417ED59'></u>
          <i id='B53417ED59'><strike id='B53417ED59'><tt id='B53417ED59'><pre id='B53417ED59'></pre></tt></strike></i>
          
    
          
      
          
       
      
          
        
      
          
      
          
        
          
          
          
            
          
            
          
              
          
                
          comprehensive 
          
                
          
                
          
              
          
            
          
            
            
          
          
          
       
        
          
      
          
      
          
        
          
        
          
          
            
          
                           
          comprehensive  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：93174
                                  
                                    
          
                                    
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org
          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.
          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”
          advertisement
          The class website and colorful syllabus went online last month and almost instantly went viral.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          A Q&A with the global head of Boehringer Ingelheim's innovation unit
                                
                            
          Next article：  
                                      
                                          After affirmative action ruling, medical educators look to 'holistic review'
                                                                    
          
            
          
           
            
          
          
          
       
          
        
          
        
      
          
      
          
                                                
        
          focus
          
                  
          

                    
          
            
          
              
                Duchenne breakthrough therapy leaves behind pioneering families
                
          
                        
              
          
                Duchenne breakthrough therapy leaves behind pioneering families
                
          
                  
          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
                
          
                        
              
          
                In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
                
          
                  
          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                After affirmative action ruling, medical educators look to 'holistic review'
                
          
                        
              
          
                After affirmative action ruling, medical educators look to 'holistic review'
                
          
                  
          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
         
        
          
          
        
          

          
          
            
          
          
          
            
          FDA panel signals lack of confidence in Amgen cancer drug data
          
            
          AdobeTheclearanceofafirst-of-its-kindcancertreatmentmadebyAmgenisonshakiergroundfollowingaFoodandDru
          
          
          
          
          
            read more